Contineum Therapeutics (CTNM) Tax Provisions (2023)
Contineum Therapeutics' (CTNM) quarterly Tax Provisions came in at -$595000.0 in Q4 2023, down 495.0% quarter-over-quarter from -$100000.0 in Q3 2023.
Contineum Therapeutics (CTNM) Tax Provisions (2023) Analysis & Trends
Contineum Therapeutics' Tax Provisions history runs 1 years deep, the most recent figure standing at -$595000.0 for Q4 2023.
- On a quarterly basis, Tax Provisions changed N/A year-over-year to -$595000.0 in Q4 2023; TTM through Sep 2024 was -$595000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $5000.0, changed N/A from the prior year.
- Tax Provisions slipped to -$595000.0 in Q4 2023 per CTNM's latest filing, from -$100000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $729000.0 in Q2 2023 and bottomed at -$595000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Contineum Therapeutics | 536.56 Mn | 536.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -595,000.00 |
| Sep 30, 2023 | -100,000.00 |
| Jun 30, 2023 | 729,000.00 |